Dataset Information

Supplementation with dairy calcium and/or flaxseed fibers in conjunction with orlistat augments fecal fat excretion without altering ratings of gastrointestinal comfort.

ABSTRACT: BACKGROUND:Orlistat is a lipase inhibitor which reduced absorption of dietary fat by ~30% thereby inducing a weight loss; however, side effects occur as a consequence of increased colonic fat content. To test the hypothesis that most gastrointestinal side events induced by treatment with orlistat could be prevented/ameliorated by concomitant use of natural dietary components, flaxseed fiber (FF) and/or dairy calcium (Ca), binding liquid fats to more solid complexes. METHODS:A randomized controlled dietary intervention study. Thirty-eight obese adults completed a 1-week run-in period, where all participants were treated with orlistat (60 mg t.i.d) and were hereafter randomized to 12 weeks dietary supplementation with/without 5 g FF (FF+/FF-) and/or 1200 mg dairy calcium (Ca+/Ca-) in conjunction with orlistat. All feces were collected for 3 days, and diet was recorded for 5 days, during run-in and week 4. The primary end-point, gastrointestinal symptoms, was assessed biweekly. At baseline and after 12 weeks, cardiometabolic risk markers and anthropometrics were evaluated as secondary end-points. RESULTS:Both FF and Ca increased fecal fat excretion (P?=?0.02 and P?=?0.04, respectively). Although fecal fat excretion increased by ~100% in the FF+/Ca?+?group, and only by ~12% in the FF-/Ca?+?group, no interaction between FF and Ca was present, suggesting an additive effect. The fecal fat excretion was ~10 g/d higher with FF and Ca (~25 g/d) compared to fecal fat excretion with orlistat alone (~15 g/d). Mean ratings of severity of diarrhea tended to increase with Ca (P?=?0.03) but not with FF. No other gastrointestinal symptoms, or a composite score of symptoms, were affected by the dietary supplements. Body weight was reduced in all groups but did not differ between groups, whereas waist circumference was most reduced in the FF+/Ca?+?group. No effects of dietary supplements on cardiometabolic risk factors were observed, except a slight increase in diastolic blood pressure (P?=?0.03) with FF, but not Ca. CONCLUSIONS:Our results do not support an improvement in orlistat-induced gastrointestinal side effects by concomitant use of FF and Ca. However, fecal fat excretion was increased with both FF and Ca in the absence of a worsening of symptoms, warranting further studies powered to detect potential additive weight loss effects. TRIAL REGISTRATION:Ethical Committee of the Capital Region of Denmark reg. no. H-1-2010-110, 02-11-2010 database no. NCT01320228, 21-03-2011.

SUBMITTER: Kristensen M

PROVIDER: S-EPMC5297204 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Supplementation with dairy calcium and/or flaxseed fibers in conjunction with orlistat augments fecal fat excretion without altering ratings of gastrointestinal comfort.

Kristensen Mette M Juul Signe Rømer SR Sørensen Karina Vejrum KV Lorenzen Janne Kunchel JK Astrup Arne A

Nutrition & metabolism 20170207

<h4>Background</h4>Orlistat is a lipase inhibitor which reduced absorption of dietary fat by ~30% thereby inducing a weight loss; however, side effects occur as a consequence of increased colonic fat content. To test the hypothesis that most gastrointestinal side events induced by treatment with orlistat could be prevented/ameliorated by concomitant use of natural dietary components, flaxseed fiber (FF) and/or dairy calcium (Ca), binding liquid fats to more solid complexes.<h4>Methods</h4>A rand ...[more]

PMID: 28191026

Similar Datasets

Project description:Interest in the production of carbon commodities from photosynthetically fixed CO2 has focused attention on cyanobacteria as a target for metabolic engineering and pathway investigation. We investigated the redirection of carbon flux in the model cyanobacterial species, Synechococcus elongatus PCC 7942, under nitrogen deprivation, for optimized production of the industrially desirable compound, pyruvate. Under nitrogen limited conditions, excess carbon is naturally stored as the multi-branched polysaccharide, glycogen, but a block in glycogen synthesis, via knockout mutation in the gene encoding ADP-glucose pyrophosphorylase (glgC), results in the accumulation of the organic acids, pyruvate and 2-oxoglutarate, as overflow excretions into the extracellular media. The ΔglgC strain, under 48 h of N-deprivation was shown to excrete pyruvate for the first time in this strain. Additionally, by increasing culture pH, to pH 10, it was possible to substantially elevate excretion of pyruvate, suggesting the involvement of an unknown substrate/proton symporter for export. The ΔglgC mutant was also engineered to express foreign transporters for glucose and sucrose, and then grown photomixotrophically with exogenous organic carbon supply, as added 5 mM glucose or sucrose during N- deprivation. Under these conditions we observed a fourfold increase in extracellular pyruvate excretion when glucose was added, and a smaller increase with added sucrose. Although the magnitude of pyruvate excretion did not correlate with the capacity of the ΔglgC strain for bicarbonate-dependent photosynthetic O2 evolution, or with light intensity, there was, however, a positive correlation observed between the density of the starter culture prior to N-deprivation and the final extracellular pyruvate concentration. The factors that contribute to enhancement of pyruvate excretion are discussed, as well as consideration of whether the source of carbon for pyruvate excretion might be derived from photosynthetic CO2 fixation or from remobilisation of existing carbon stores.

Project description:Estimating excreted nutrients is important for farm nutrient management, but seldom occurs on commercial grazing system farms due to difficulties in quantifying pasture intake. Nitrogen (N), phosphorus (P), potassium (K), sulphur (S), calcium (Ca) and magnesium (Mg) intake, excretion and use efficiency of 43 commercial dairy herds grazing pasture were calculated to understand the range in nutrient intake and excretion in these systems. Milk production, feed (grazed and supplement), as well as farm and herd management data were collected quarterly on representative farms located in temperate, arid, subtropical and tropical regions of Australia. Lactating herd sizes on these farms averaged 267 (30 to 1350) cows, with an average daily milk yield of 22 (9 to 36) kg/cow per day and the herds walked from <0.01 to 4 km/day on a variety of terrains. The mean total metabolizable energy (ME) required by cows in the herds was estimated to be 195 (116 to 289) MJ/cow per day. Although these farms are considered grazing systems, feeding strategies ranged from total dependence on pasture to total mixed rations (TMRTMR) and consisted of a wide variety of nutrient and energy contents. Mean pasture dry matter intake (DMI) (9 kg/cow per day, from 0.1 to 22 kg/cow per day) was just over half of total DMI. Dietary concentration of crude protein, P, K, S, Ca and Mg concentrations were, on average, 19%, 0.45%, 2.1%, 0.29%, 0.65%, and 0.3%, respectively, for all herds and, except for N, supplement nutrient concentrations were always more variable than pasture. Approximately 72% and 88% of diets provided greater than recommended P and N intakes, respectively. Calculated mean N, P, K, S, Ca and Mg excretions were 433, 61, 341, 44, 92 and 52 g/cow per day, respectively. Of the farm characteristics examined, residual maximum likelihood (REML) analysis indicated that daily excreted N, P and S were significantly related to per ha milk production, and excreted P, K and Mg were related to percentage of herd DMI provided as supplement. Mean use efficiencies by cows of N, P, K, S, Ca and Mg were 21%, 25%, 9%, 16%, 23% and 4%, respectively. These estimates of nutrient excretion and feed nutrient use efficiencies can be used to improve nutrient management on grazing system commercial dairy farms.

Dataset Information

Supplementation with dairy calcium and/or flaxseed fibers in conjunction with orlistat augments fecal fat excretion without altering ratings of gastrointestinal comfort.

Publications

Supplementation with dairy calcium and/or flaxseed fibers in conjunction with orlistat augments fecal fat excretion without altering ratings of gastrointestinal comfort.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets